SAVA Takes the Lead in Addressing Veterinary Medicine Shortages

The South African Veterinary Association (SAVA) is taking decisive action to address the critical shortage of essential veterinary medicines. Recognizing the severity of the issue, SAVA has initiated discussions with the Minister of Agriculture, Land Reform and Rural Development (DALRRD) Mr John Steenhuisen to find urgent solutions that will enable veterinarians to access the medications they need to treat their animal patients effectively. 

Veterinarians across the country are well aware of the impact that restrictive regulations have had on the availability of key veterinary medicines. Compounded treatments, which have long been an essential part of veterinary care, are becoming increasingly difficult to access, putting the health and welfare of animals at risk. The inability to obtain crucial medicines such as Trilostane for Cushing’s disease in dogs, Yohimbine for wildlife anaesthesia, and Pergolide for the treatment of Cushing’s disease in horses is exacerbating an already dire situation. 

In response, SAVA has stepped forward to lead high-level discussions with government officials, emphasising the urgency of the matter. The association is engaging directly with Mr Steenhuisen to push for regulatory adjustments that will allow veterinarians to continue providing essential care without unnecessary bureaucratic obstacles. SAVA is advocating for practical, science-based solutions that balance the need for oversight with the realities of veterinary practice. 

V-Tech, a key player in veterinary pharmaceutical compounding, has been working alongside SAVA to provide industry expertise and ensure that the voices of veterinarians are heard in these discussions. The goal is to secure sustainable access to vital veterinary medicines while maintaining the highest standards of safety and efficacy. 

The veterinary profession plays a crucial role in animal health, food safety and security, and public health. Without immediate action, the ongoing shortages will continue to hinder veterinarians’ ability to treat their patients effectively. By taking a proactive stance, SAVA is ensuring that veterinarians have a strong advocate at the highest levels of government. SAVA has outlined several key solutions to address these challenges. These include the establishment of a Ministerial Veterinary Advisory Committee to advise the Minister of Health on veterinary matters inclusive of veterinary medicines, the exemption of vital compounded veterinary medicines from restrictive regulatory requirements, and clear guidelines on the importation and use of active pharmaceutical ingredients (APIs). Additionally, SAVA is advocating for policy adjustments that recognise the unique needs of veterinary medicine through the establishment of a Veterinary Medicine Act, ensuring that veterinarians have the necessary tools to provide effective treatment. Through continued engagement with Mr Steenhuisen, SAVA aims to implement these measures to safeguard animal welfare and support the veterinary profession in delivering quality care.